BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19765131)

  • 1. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.
    Hong Z; Moessler H; Bornstein N; Brainin M; Heiss WD;
    Int J Stroke; 2009 Oct; 4(5):406-12. PubMed ID: 19765131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 5. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
    Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
    Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
    Stan A; Birle C; Blesneag A; Iancu M
    J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
    [No Abstract]   [Full Text] [Related]  

  • 9. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
    Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
    Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.
    Woo PYM; Ho JWK; Ko NMW; Li RPT; Jian L; Chu ACH; Kwan MCL; Chan Y; Wong AKS; Wong HT; Chan KY; Kwok JCK
    BMC Neurol; 2020 Nov; 20(1):401. PubMed ID: 33143640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial.
    Liu X; Wang L; Wen A; Yang J; Yan Y; Song Y; Liu X; Ren H; Wu Y; Li Z; Chen W; Xu Y; Li L; Xia J; Zhao G
    Eur J Neurol; 2012 Jun; 19(6):855-63. PubMed ID: 22233205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
    Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J
    Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
    Grotta J
    Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.